Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Apr 19;11(20):3796–3808. doi: 10.1002/cam4.4763

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.

This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

(A) Overall survival stratified by age group in elderly patients. Cumulative overall survival at 3, 6, and 9 months was 96.0%, 88.9%, and 84.2% in elderly patients aged 75–79 years (dotted line), 93.6%, 90.1%, and 86.5% in elderly patients aged 80–84 years (solid line), and 100.0%, 92.3%, and 73.8% in elderly patients aged ≥85 years (dash‐dot‐dash line), respectively (p = 0.960). (B) Progression‐free survival stratified by age group in elderly patients. Cumulative progression‐free survival at 3 and 6 months was 80.2% and 57.3% in elderly patients aged 75–79 years (dotted line), 75.3% and 42.7% in elderly patients aged 80–84 years (solid line), and 71.4% and 49.4% in elderly patients aged ≥85 years (dash‐dot‐dash line), respectively (p = 0.566).